Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/34281
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSingh, Sima-
dc.contributor.authorLal, Uma Ranjan-
dc.date.accessioned2016-06-02T21:13:56Z-
dc.date.available2016-06-02T21:13:56Z-
dc.date.issued2016-07-
dc.identifier.issn0975-1068 (Online); 0972-5938 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/34281-
dc.description440-446en_US
dc.description.abstractUlcerative colitis (UC) is a wide-reaching health problem with unknown etiology and its high mortality rates. Conventional therapy for onset treatment of active UC includes immunomodulators, corticosteroids, purine analogues, antibiotics and 5-aminosalicylic acid. Unfortunately, after giving long term treatment to the patients associated with UC, these drugs are found to have undue side effects. There is a need for novel therapeutical agents which is least toxic, effective and economical. Experimental data from the preclinical studies suggested that curcumin, a natural polyphenol molecule derived from the Curcuma longa is effective in preventing ulcerative colitis. The present work is divided into two sections: 1) multiparticulate delivery of curcumin loaded granules to the colon and it’s in vivo evaluation, 2) co-administration of curcumin along with probiotics to demonstrate significant protective action against acetic acid-induced UC in rats. Experimental research work is mainly focused on the induction of colitis, assessment of colitis, diarrhoea assessment, change in body weight, fecal bleeding assessment, blood analysis and histopathological study of colonic sections. In conclusion, our results suggest that the co-administration of probiotics along with colon targeted delivery of curcumin showed potential beneficial protective effect against acetic acid induced UC in rats.en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.relation.ispartofseriesInt. Cl.8: A61K 36/00, A01D 20/48, A01D 20/00, C07Hen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJTK Vol.15(3) [July 2016]en_US
dc.subjectCurcuminen_US
dc.subjectUlcerative colitisen_US
dc.subjectGuar-gumen_US
dc.subjectPolysaccharidesen_US
dc.subjectProbioticsen_US
dc.titleIn vivo evaluation of curcumin loaded granules using Eudragit FS30D and Guar-gum coating in the treatment of ulcerative colitis in albino ratsen_US
dc.typeArticleen_US
Appears in Collections:IJTK Vol.15(3) [July 2016]

Files in This Item:
File Description SizeFormat 
IJTK 15(3) 440-446.pdf171.24 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.